Upcoming

2023

Poultry Vaccine Market

Poultry Vaccine Market: Global Opportunity Analysis and Industry Forecast, 2019-2027 Market

LS : Pharmaceuticals	Report Code: A10460	Nov 2023 \| Pages: NA
Tables: NA	Charts: NA	Formats*: Single User License, Five User License & Enterprise User License Data Pack Excel License It comes with the additional cost of $2500.00 contact sales.

COVID-19

Pandemic disrupted the entire world and affected many industries.

Get detailed COVID-19 impact analysis on the Poultry Vaccine Market

Request Now !

Poultry Vaccine is considered as most important part of health management of poultry. It is used to prevent a particular disease and help to boost the immunity of poultry to produce antibody that protect the poultry from infectious disease. Vaccine is an important component to control disease. There are various routes of administration for vaccinating the poultry such as nasal, oral, subcutaneous ocular, in-vivo intramuscular and others. While vaccinating the chicken, it is applied on different areas of egg such as body of embryo, allantois sac, yolk sac, amniotic fluid. Important thing that have to maintain during in-vivo vaccination such as maintain air filter, adjust weather condition, reduce air circulation, and maintain hatchery insulation. CVB Center for veterinary Biologic grant the permission to animal health companies to manufacture and sell veterinary biologics. The global poultry vaccine market is experiencing a significant growth, and will grow considerably in next few years.

Poultry-Vaccination

COVID-19 Scenario Analysis:

Pharmaceutical and biotech companies together with governments around the globe are working to address the COVID-19 outbreak, from supporting the development of vaccines to planning for medicines supply chain challenges. Currently, around 115 vaccine candidates and 155 molecules are in the R&D pipeline. Moreover, commonly used drugs such as Hydroxychloroquine have witnessed dramatic surge in demand for the management of COVID-19. Such high demand for these drugs has presented huge opportunity for manufacturers of COVID-19 management drugs, as many developed countries are short of these drugs.Owing to the demand for vaccine and treatment drugs for COVID-19, the pharmaceutical and biotechnology industry is expected to witness a significant growth in the future. Ongoing COVID -19 Pandemic is affecting the poultry vaccine market. It mostly affects the vaccine production industries, it decreases the demand and supply chain of the product as well as affects poultry sale and distribution, as because of growing infectious diseases, consumer is not ready to buy the poultry product, which decreases the poultry market growth.

Top impacting factors: Market Scenario Analysis, Trends, Drivers and Impact Analysis:

In 2017, the United States Department of Agriculture (USDA) reported that total 108.6 pounds of consumers consumed poultry products. According to Merial Health, by 2020, chicken is expected to overtake pork as the animal protein of choice globally. Thus, the poultry industry plays a vital role in ensuring food for the future global population. As per National Chicken Council, in 2018, per capita consumption of poultry was 109.5 pound.

Globally, North America is the most dominating region in the market due to rising production of egg, rising consumer awareness about the food safety, rising consumption of poultry derived product, growing zoonotic diseases related with poultry, growing advancement in vaccine development such as development of live gene deleted vaccine, non- replicating recombinant antigen vaccine, live vector vaccine, and nucleic acid mediated vaccines. Whereas, Europe is considered as the second largest market for poultry vaccine in the world. Asia-Pacific is expected to increase growth rate of the poultry vaccine market due to increasing veterinary healthcare expenditure, rising government vaccination program, growing poultry production and India is considered as the second fastest growing market for processed meat.

The driving factors are - increasing vaccine innovation, cost-effective animal health expenditure, rising demand for poultry vaccination, poultry derived food product, rising technological advancement, increasing prevalence of zoonotic disease, increasing poultry population, rising government initiative in poultry treatment, and increasing vaccination program by leading industries. The factor that restrain the market growth of poultry vaccine are - increasing cost of vaccine, increasing acceptance of vegetarian food, decreasing production of advanced vaccine and increasing investment in animal health.

New product launches to flourish the market

The launch of new product that contain improved capabilities have been launched by leading market player. They have taken necessary steps to improve accuracy of devices and overall functionality as well. MSD Animal Health used biotechnology to launch the world first dual construct Herpes Virus of Turkeys (HVT) vaccine that simultaneously protects the birds from infectious Bursal, Newcastle and Mareck’s disease. Merial the animal health division of Sanofi launched the new product such as, The AvinewTM Neo Effervescent tablet vaccine, which helps to treat the Newcastle Disease Virus (NDV). “Merial Avinew Vaccine” is the world number one vaccine.

Key benefits of the report:

This study presents the analytical depiction of the global poultry vaccine market industry along with the current trends and future estimations to determine the imminent investment pockets.
The report presents information related to key drivers, restraints, and opportunities along with detailed analysis of the global thermistor market share.
The current market is quantitatively analyzed to highlight the global poultry vaccine market growth scenario.
Porter’s five forces analysis illustrates the potency of buyers & suppliers in the market.
The report provides a detailed global poultry vaccine market analysis based on competitive intensity and how the competition will take shape in coming years.

Questions answered in the poultry vaccine market research report:

What are the leading market players active in the poultry vaccine market?
What the current trends will influence the market in the next few years?
What are the driving factors, restraints, and opportunities in the poultry vaccine market?
What are the projections for the future that would help in taking further strategic steps?

Poultry Vaccine Market: Global Opportunity Analysis and Industry Forecast, 2019–2027 Report Highlights

Aspects	Details
By Disease Type	Avian Influenza Infectious Bronchitis
By Product Type	Recombinant Vaccine Live Attenuated Vaccine Inactivated Vaccine Others
By Dosage Form	Liquid Vaccine Freeze Dried Vaccine
By Application	Breeder Broiler
By End User	Veterinary Hospitals Poultry Firm Poultry Vaccination Center
By Region	North America (U.S., Canada, Mexico) Europe (France, Germany, Italy, Spain, UK, Rest of Europe) Asia-Pacific (China, Japan, India, South Korea, Australia, Rest of Asia-Pacific) LAMEA (Brazil, South Africa, Saudi Arabia, Rest of LAMEA)
Key Market Players	Biovac, Zoetis Inc.,, Anicon GmbH, Phibro Animal Health Corporation, Ceva Animal Health,, Merck & co.,, Bio-vet,, Ringpu Biology,, Hester Biosciences Limited,, Borhringer Ingelheim,, Venkys,

CHAPTER 1: INTRODUCTION
- 1.1. Report Description
- 1.2. Key Market Segments
- 1.3. Key Benefits
- 1.4. Research Methodology
  - 1.4.1. Primary Research
  - 1.4.2. Secondary Research
  - 1.4.3. Analyst Tools and Models
CHAPTER 2: EXECUTIVE SUMMARY
- 2.1. CXO Perspective
CHAPTER 3: MARKET LANDSCAPE
- 3.1. Market Definition and Scope
- 3.2. Key Findings
  - 3.2.1. Top Investment Pockets
  - 3.2.2. Top Winning Strategies
- 3.3. Porter's Five Forces Analysis
  - 3.3.1. Bargaining Power of Suppliers
  - 3.3.2. Threat of New Entrants
  - 3.3.3. Threat of Substitutes
  - 3.3.4. Competitive Rivalry
  - 3.3.5. Bargaining Power among Buyers
- 3.5. Market Dynamics
  - 3.5.1. Drivers
  - 3.5.2. Restraints
  - 3.5.3. Opportunities
- 3.6. COVID-19 Impact Analysis
CHAPTER 4: POULTRY VACCINE MARKET, BY DISEASE TYPE
- 4.1. Market Overview
  - 4.1.1 Market Size and Forecast, By Disease Type
- 4.2. Avian Influenza
  - 4.2.1. Key Market Trends, Growth Factors and Opportunities
  - 4.2.2. Market Size and Forecast, By Region
  - 4.2.3. Market Share Analysis, By Country
- 4.3. Infectious Bronchitis
  - 4.3.1. Key Market Trends, Growth Factors and Opportunities
  - 4.3.2. Market Size and Forecast, By Region
  - 4.3.3. Market Share Analysis, By Country
CHAPTER 5: POULTRY VACCINE MARKET, BY PRODUCT TYPE
- 5.1. Market Overview
  - 5.1.1 Market Size and Forecast, By Product Type
- 5.2. Recombinant Vaccine
  - 5.2.1. Key Market Trends, Growth Factors and Opportunities
  - 5.2.2. Market Size and Forecast, By Region
  - 5.2.3. Market Share Analysis, By Country
- 5.3. Live Attenuated Vaccine
  - 5.3.1. Key Market Trends, Growth Factors and Opportunities
  - 5.3.2. Market Size and Forecast, By Region
  - 5.3.3. Market Share Analysis, By Country
- 5.4. Inactivated Vaccine
  - 5.4.1. Key Market Trends, Growth Factors and Opportunities
  - 5.4.2. Market Size and Forecast, By Region
  - 5.4.3. Market Share Analysis, By Country
- 5.5. Others
  - 5.5.1. Key Market Trends, Growth Factors and Opportunities
  - 5.5.2. Market Size and Forecast, By Region
  - 5.5.3. Market Share Analysis, By Country
CHAPTER 6: POULTRY VACCINE MARKET, BY DOSAGE FORM
- 6.1. Market Overview
  - 6.1.1 Market Size and Forecast, By Dosage Form
- 6.2. Liquid Vaccine
  - 6.2.1. Key Market Trends, Growth Factors and Opportunities
  - 6.2.2. Market Size and Forecast, By Region
  - 6.2.3. Market Share Analysis, By Country
- 6.3. Freeze Dried Vaccine
  - 6.3.1. Key Market Trends, Growth Factors and Opportunities
  - 6.3.2. Market Size and Forecast, By Region
  - 6.3.3. Market Share Analysis, By Country
CHAPTER 7: POULTRY VACCINE MARKET, BY APPLICATION
- 7.1. Market Overview
  - 7.1.1 Market Size and Forecast, By Application
- 7.2. Breeder
  - 7.2.1. Key Market Trends, Growth Factors and Opportunities
  - 7.2.2. Market Size and Forecast, By Region
  - 7.2.3. Market Share Analysis, By Country
- 7.3. Broiler
  - 7.3.1. Key Market Trends, Growth Factors and Opportunities
  - 7.3.2. Market Size and Forecast, By Region
  - 7.3.3. Market Share Analysis, By Country
CHAPTER 8: POULTRY VACCINE MARKET, BY END USER
- 8.1. Market Overview
  - 8.1.1 Market Size and Forecast, By End User
- 8.2. Veterinary Hospitals
  - 8.2.1. Key Market Trends, Growth Factors and Opportunities
  - 8.2.2. Market Size and Forecast, By Region
  - 8.2.3. Market Share Analysis, By Country
- 8.3. Poultry Firm
  - 8.3.1. Key Market Trends, Growth Factors and Opportunities
  - 8.3.2. Market Size and Forecast, By Region
  - 8.3.3. Market Share Analysis, By Country
- 8.4. Poultry Vaccination Center
  - 8.4.1. Key Market Trends, Growth Factors and Opportunities
  - 8.4.2. Market Size and Forecast, By Region
  - 8.4.3. Market Share Analysis, By Country
CHAPTER 9: POULTRY VACCINE MARKET, BY REGION
- 9.1. Market Overview
  - 9.1.1 Market Size and Forecast, By Region
- 9.2. North America
  - 9.2.1. Key Market Trends and Opportunities
  - 9.2.2. Market Size and Forecast, By Disease Type
  - 9.2.3. Market Size and Forecast, By Product Type
  - 9.2.4. Market Size and Forecast, By Dosage Form
  - 9.2.5. Market Size and Forecast, By Application
  - 9.2.6. Market Size and Forecast, By End User
  - 9.2.7. Market Size and Forecast, By Country
  - 9.2.8. U.S. Poultry Vaccine Market
    - 9.2.8.1. Market Size and Forecast, By Disease Type
    - 9.2.8.2. Market Size and Forecast, By Product Type
    - 9.2.8.3. Market Size and Forecast, By Dosage Form
    - 9.2.8.4. Market Size and Forecast, By Application
    - 9.2.8.5. Market Size and Forecast, By End User
  - 9.2.9. Canada Poultry Vaccine Market
    - 9.2.9.1. Market Size and Forecast, By Disease Type
    - 9.2.9.2. Market Size and Forecast, By Product Type
    - 9.2.9.3. Market Size and Forecast, By Dosage Form
    - 9.2.9.4. Market Size and Forecast, By Application
    - 9.2.9.5. Market Size and Forecast, By End User
  - 9.2.10. Mexico Poultry Vaccine Market
    - 9.2.10.1. Market Size and Forecast, By Disease Type
    - 9.2.10.2. Market Size and Forecast, By Product Type
    - 9.2.10.3. Market Size and Forecast, By Dosage Form
    - 9.2.10.4. Market Size and Forecast, By Application
    - 9.2.10.5. Market Size and Forecast, By End User
- 9.3. Europe
  - 9.3.1. Key Market Trends and Opportunities
  - 9.3.2. Market Size and Forecast, By Disease Type
  - 9.3.3. Market Size and Forecast, By Product Type
  - 9.3.4. Market Size and Forecast, By Dosage Form
  - 9.3.5. Market Size and Forecast, By Application
  - 9.3.6. Market Size and Forecast, By End User
  - 9.3.7. Market Size and Forecast, By Country
  - 9.3.8. France Poultry Vaccine Market
    - 9.3.8.1. Market Size and Forecast, By Disease Type
    - 9.3.8.2. Market Size and Forecast, By Product Type
    - 9.3.8.3. Market Size and Forecast, By Dosage Form
    - 9.3.8.4. Market Size and Forecast, By Application
    - 9.3.8.5. Market Size and Forecast, By End User
  - 9.3.9. Germany Poultry Vaccine Market
    - 9.3.9.1. Market Size and Forecast, By Disease Type
    - 9.3.9.2. Market Size and Forecast, By Product Type
    - 9.3.9.3. Market Size and Forecast, By Dosage Form
    - 9.3.9.4. Market Size and Forecast, By Application
    - 9.3.9.5. Market Size and Forecast, By End User
  - 9.3.10. Italy Poultry Vaccine Market
    - 9.3.10.1. Market Size and Forecast, By Disease Type
    - 9.3.10.2. Market Size and Forecast, By Product Type
    - 9.3.10.3. Market Size and Forecast, By Dosage Form
    - 9.3.10.4. Market Size and Forecast, By Application
    - 9.3.10.5. Market Size and Forecast, By End User
  - 9.3.11. Spain Poultry Vaccine Market
    - 9.3.11.1. Market Size and Forecast, By Disease Type
    - 9.3.11.2. Market Size and Forecast, By Product Type
    - 9.3.11.3. Market Size and Forecast, By Dosage Form
    - 9.3.11.4. Market Size and Forecast, By Application
    - 9.3.11.5. Market Size and Forecast, By End User
  - 9.3.12. UK Poultry Vaccine Market
    - 9.3.12.1. Market Size and Forecast, By Disease Type
    - 9.3.12.2. Market Size and Forecast, By Product Type
    - 9.3.12.3. Market Size and Forecast, By Dosage Form
    - 9.3.12.4. Market Size and Forecast, By Application
    - 9.3.12.5. Market Size and Forecast, By End User
  - 9.3.13. Russia Poultry Vaccine Market
    - 9.3.13.1. Market Size and Forecast, By Disease Type
    - 9.3.13.2. Market Size and Forecast, By Product Type
    - 9.3.13.3. Market Size and Forecast, By Dosage Form
    - 9.3.13.4. Market Size and Forecast, By Application
    - 9.3.13.5. Market Size and Forecast, By End User
  - 9.3.14. Rest Of Europe Poultry Vaccine Market
    - 9.3.14.1. Market Size and Forecast, By Disease Type
    - 9.3.14.2. Market Size and Forecast, By Product Type
    - 9.3.14.3. Market Size and Forecast, By Dosage Form
    - 9.3.14.4. Market Size and Forecast, By Application
    - 9.3.14.5. Market Size and Forecast, By End User
- 9.4. Asia-Pacific
  - 9.4.1. Key Market Trends and Opportunities
  - 9.4.2. Market Size and Forecast, By Disease Type
  - 9.4.3. Market Size and Forecast, By Product Type
  - 9.4.4. Market Size and Forecast, By Dosage Form
  - 9.4.5. Market Size and Forecast, By Application
  - 9.4.6. Market Size and Forecast, By End User
  - 9.4.7. Market Size and Forecast, By Country
  - 9.4.8. China Poultry Vaccine Market
    - 9.4.8.1. Market Size and Forecast, By Disease Type
    - 9.4.8.2. Market Size and Forecast, By Product Type
    - 9.4.8.3. Market Size and Forecast, By Dosage Form
    - 9.4.8.4. Market Size and Forecast, By Application
    - 9.4.8.5. Market Size and Forecast, By End User
  - 9.4.9. Japan Poultry Vaccine Market
    - 9.4.9.1. Market Size and Forecast, By Disease Type
    - 9.4.9.2. Market Size and Forecast, By Product Type
    - 9.4.9.3. Market Size and Forecast, By Dosage Form
    - 9.4.9.4. Market Size and Forecast, By Application
    - 9.4.9.5. Market Size and Forecast, By End User
  - 9.4.10. India Poultry Vaccine Market
    - 9.4.10.1. Market Size and Forecast, By Disease Type
    - 9.4.10.2. Market Size and Forecast, By Product Type
    - 9.4.10.3. Market Size and Forecast, By Dosage Form
    - 9.4.10.4. Market Size and Forecast, By Application
    - 9.4.10.5. Market Size and Forecast, By End User
  - 9.4.11. South Korea Poultry Vaccine Market
    - 9.4.11.1. Market Size and Forecast, By Disease Type
    - 9.4.11.2. Market Size and Forecast, By Product Type
    - 9.4.11.3. Market Size and Forecast, By Dosage Form
    - 9.4.11.4. Market Size and Forecast, By Application
    - 9.4.11.5. Market Size and Forecast, By End User
  - 9.4.12. Australia Poultry Vaccine Market
    - 9.4.12.1. Market Size and Forecast, By Disease Type
    - 9.4.12.2. Market Size and Forecast, By Product Type
    - 9.4.12.3. Market Size and Forecast, By Dosage Form
    - 9.4.12.4. Market Size and Forecast, By Application
    - 9.4.12.5. Market Size and Forecast, By End User
  - 9.4.13. Thailand Poultry Vaccine Market
    - 9.4.13.1. Market Size and Forecast, By Disease Type
    - 9.4.13.2. Market Size and Forecast, By Product Type
    - 9.4.13.3. Market Size and Forecast, By Dosage Form
    - 9.4.13.4. Market Size and Forecast, By Application
    - 9.4.13.5. Market Size and Forecast, By End User
  - 9.4.14. Malaysia Poultry Vaccine Market
    - 9.4.14.1. Market Size and Forecast, By Disease Type
    - 9.4.14.2. Market Size and Forecast, By Product Type
    - 9.4.14.3. Market Size and Forecast, By Dosage Form
    - 9.4.14.4. Market Size and Forecast, By Application
    - 9.4.14.5. Market Size and Forecast, By End User
  - 9.4.15. Indonesia Poultry Vaccine Market
    - 9.4.15.1. Market Size and Forecast, By Disease Type
    - 9.4.15.2. Market Size and Forecast, By Product Type
    - 9.4.15.3. Market Size and Forecast, By Dosage Form
    - 9.4.15.4. Market Size and Forecast, By Application
    - 9.4.15.5. Market Size and Forecast, By End User
  - 9.4.16. Rest of Asia Pacific Poultry Vaccine Market
    - 9.4.16.1. Market Size and Forecast, By Disease Type
    - 9.4.16.2. Market Size and Forecast, By Product Type
    - 9.4.16.3. Market Size and Forecast, By Dosage Form
    - 9.4.16.4. Market Size and Forecast, By Application
    - 9.4.16.5. Market Size and Forecast, By End User
- 9.5. LAMEA
  - 9.5.1. Key Market Trends and Opportunities
  - 9.5.2. Market Size and Forecast, By Disease Type
  - 9.5.3. Market Size and Forecast, By Product Type
  - 9.5.4. Market Size and Forecast, By Dosage Form
  - 9.5.5. Market Size and Forecast, By Application
  - 9.5.6. Market Size and Forecast, By End User
  - 9.5.7. Market Size and Forecast, By Country
  - 9.5.8. Brazil Poultry Vaccine Market
    - 9.5.8.1. Market Size and Forecast, By Disease Type
    - 9.5.8.2. Market Size and Forecast, By Product Type
    - 9.5.8.3. Market Size and Forecast, By Dosage Form
    - 9.5.8.4. Market Size and Forecast, By Application
    - 9.5.8.5. Market Size and Forecast, By End User
  - 9.5.9. South Africa Poultry Vaccine Market
    - 9.5.9.1. Market Size and Forecast, By Disease Type
    - 9.5.9.2. Market Size and Forecast, By Product Type
    - 9.5.9.3. Market Size and Forecast, By Dosage Form
    - 9.5.9.4. Market Size and Forecast, By Application
    - 9.5.9.5. Market Size and Forecast, By End User
  - 9.5.10. Saudi Arabia Poultry Vaccine Market
    - 9.5.10.1. Market Size and Forecast, By Disease Type
    - 9.5.10.2. Market Size and Forecast, By Product Type
    - 9.5.10.3. Market Size and Forecast, By Dosage Form
    - 9.5.10.4. Market Size and Forecast, By Application
    - 9.5.10.5. Market Size and Forecast, By End User
  - 9.5.11. UAE Poultry Vaccine Market
    - 9.5.11.1. Market Size and Forecast, By Disease Type
    - 9.5.11.2. Market Size and Forecast, By Product Type
    - 9.5.11.3. Market Size and Forecast, By Dosage Form
    - 9.5.11.4. Market Size and Forecast, By Application
    - 9.5.11.5. Market Size and Forecast, By End User
  - 9.5.12. Argentina Poultry Vaccine Market
    - 9.5.12.1. Market Size and Forecast, By Disease Type
    - 9.5.12.2. Market Size and Forecast, By Product Type
    - 9.5.12.3. Market Size and Forecast, By Dosage Form
    - 9.5.12.4. Market Size and Forecast, By Application
    - 9.5.12.5. Market Size and Forecast, By End User
  - 9.5.13. Rest of LAMEA Poultry Vaccine Market
    - 9.5.13.1. Market Size and Forecast, By Disease Type
    - 9.5.13.2. Market Size and Forecast, By Product Type
    - 9.5.13.3. Market Size and Forecast, By Dosage Form
    - 9.5.13.4. Market Size and Forecast, By Application
    - 9.5.13.5. Market Size and Forecast, By End User
CHAPTER 10: COMPETITIVE LANDSCAPE
- 10.1. Introduction
- 10.2. Top Winning Strategies
- 10.3. Product Mapping Of Top 10 Player
- 10.4. Competitive Dashboard
- 10.5. Competitive Heatmap
- 10.6. Top Player Positioning,2022
CHAPTER 11: COMPANY PROFILES
- 11.1. Hester Biosciences Limited,
  - 11.1.1. Company Overview
  - 11.1.2. Key Executives
  - 11.1.3. Company Snapshot
  - 11.1.4. Operating Business Segments
  - 11.1.5. Product Portfolio
  - 11.1.6. Business Performance
  - 11.1.7. Key Strategic Moves and Developments
- 11.2. Biovac, Zoetis Inc.,
  - 11.2.1. Company Overview
  - 11.2.2. Key Executives
  - 11.2.3. Company Snapshot
  - 11.2.4. Operating Business Segments
  - 11.2.5. Product Portfolio
  - 11.2.6. Business Performance
  - 11.2.7. Key Strategic Moves and Developments
- 11.3. Merck And Co.,
  - 11.3.1. Company Overview
  - 11.3.2. Key Executives
  - 11.3.3. Company Snapshot
  - 11.3.4. Operating Business Segments
  - 11.3.5. Product Portfolio
  - 11.3.6. Business Performance
  - 11.3.7. Key Strategic Moves and Developments
- 11.4. Borhringer Ingelheim,
  - 11.4.1. Company Overview
  - 11.4.2. Key Executives
  - 11.4.3. Company Snapshot
  - 11.4.4. Operating Business Segments
  - 11.4.5. Product Portfolio
  - 11.4.6. Business Performance
  - 11.4.7. Key Strategic Moves and Developments
- 11.5. Bio-vet,
  - 11.5.1. Company Overview
  - 11.5.2. Key Executives
  - 11.5.3. Company Snapshot
  - 11.5.4. Operating Business Segments
  - 11.5.5. Product Portfolio
  - 11.5.6. Business Performance
  - 11.5.7. Key Strategic Moves and Developments
- 11.6. Ceva Animal Health,
  - 11.6.1. Company Overview
  - 11.6.2. Key Executives
  - 11.6.3. Company Snapshot
  - 11.6.4. Operating Business Segments
  - 11.6.5. Product Portfolio
  - 11.6.6. Business Performance
  - 11.6.7. Key Strategic Moves and Developments
- 11.7. Phibro Animal Health Corporation
  - 11.7.1. Company Overview
  - 11.7.2. Key Executives
  - 11.7.3. Company Snapshot
  - 11.7.4. Operating Business Segments
  - 11.7.5. Product Portfolio
  - 11.7.6. Business Performance
  - 11.7.7. Key Strategic Moves and Developments
- 11.8. Venkys,
  - 11.8.1. Company Overview
  - 11.8.2. Key Executives
  - 11.8.3. Company Snapshot
  - 11.8.4. Operating Business Segments
  - 11.8.5. Product Portfolio
  - 11.8.6. Business Performance
  - 11.8.7. Key Strategic Moves and Developments
- 11.9. Ringpu Biology,
  - 11.9.1. Company Overview
  - 11.9.2. Key Executives
  - 11.9.3. Company Snapshot
  - 11.9.4. Operating Business Segments
  - 11.9.5. Product Portfolio
  - 11.9.6. Business Performance
  - 11.9.7. Key Strategic Moves and Developments
- 11.10. Anicon GmbH
  - 11.10.1. Company Overview
  - 11.10.2. Key Executives
  - 11.10.3. Company Snapshot
  - 11.10.4. Operating Business Segments
  - 11.10.5. Product Portfolio
  - 11.10.6. Business Performance
  - 11.10.7. Key Strategic Moves and Developments

LIST OF TABLES
TABLE 1. GLOBAL POULTRY VACCINE MARKET, BY DISEASE TYPE, 2022-2032 ($MILLION)
TABLE 2. GLOBAL POULTRY VACCINE MARKET FOR AVIAN INFLUENZA, BY REGION, 2022-2032 ($MILLION)
TABLE 3. GLOBAL POULTRY VACCINE MARKET FOR INFECTIOUS BRONCHITIS, BY REGION, 2022-2032 ($MILLION)
TABLE 4. GLOBAL POULTRY VACCINE MARKET, BY PRODUCT TYPE, 2022-2032 ($MILLION)
TABLE 5. GLOBAL POULTRY VACCINE MARKET FOR RECOMBINANT VACCINE, BY REGION, 2022-2032 ($MILLION)
TABLE 6. GLOBAL POULTRY VACCINE MARKET FOR LIVE ATTENUATED VACCINE, BY REGION, 2022-2032 ($MILLION)
TABLE 7. GLOBAL POULTRY VACCINE MARKET FOR INACTIVATED VACCINE, BY REGION, 2022-2032 ($MILLION)
TABLE 8. GLOBAL POULTRY VACCINE MARKET FOR OTHERS, BY REGION, 2022-2032 ($MILLION)
TABLE 9. GLOBAL POULTRY VACCINE MARKET, BY DOSAGE FORM, 2022-2032 ($MILLION)
TABLE 10. GLOBAL POULTRY VACCINE MARKET FOR LIQUID VACCINE, BY REGION, 2022-2032 ($MILLION)
TABLE 11. GLOBAL POULTRY VACCINE MARKET FOR FREEZE DRIED VACCINE, BY REGION, 2022-2032 ($MILLION)
TABLE 12. GLOBAL POULTRY VACCINE MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 13. GLOBAL POULTRY VACCINE MARKET FOR BREEDER, BY REGION, 2022-2032 ($MILLION)
TABLE 14. GLOBAL POULTRY VACCINE MARKET FOR BROILER, BY REGION, 2022-2032 ($MILLION)
TABLE 15. GLOBAL POULTRY VACCINE MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 16. GLOBAL POULTRY VACCINE MARKET FOR VETERINARY HOSPITALS, BY REGION, 2022-2032 ($MILLION)
TABLE 17. GLOBAL POULTRY VACCINE MARKET FOR POULTRY FIRM, BY REGION, 2022-2032 ($MILLION)
TABLE 18. GLOBAL POULTRY VACCINE MARKET FOR POULTRY VACCINATION CENTER, BY REGION, 2022-2032 ($MILLION)
TABLE 19. GLOBAL POULTRY VACCINE MARKET, BY REGION, 2022-2032 ($MILLION)
TABLE 20. NORTH AMERICA POULTRY VACCINE, BY REGION, 2022-2032 ($MILLION)
TABLE 21. NORTH AMERICA POULTRY VACCINE, BY DISEASE TYPE, 2022-2032 ($MILLION)
TABLE 22. NORTH AMERICA POULTRY VACCINE, BY PRODUCT TYPE, 2022-2032 ($MILLION)
TABLE 23. NORTH AMERICA POULTRY VACCINE, BY DOSAGE FORM, 2022-2032 ($MILLION)
TABLE 24. NORTH AMERICA POULTRY VACCINE, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 25. NORTH AMERICA POULTRY VACCINE, BY END USER, 2022-2032 ($MILLION)
TABLE 26. U.S. POULTRY VACCINE, BY DISEASE TYPE, 2022-2032 ($MILLION)
TABLE 27. U.S. POULTRY VACCINE, BY PRODUCT TYPE, 2022-2032 ($MILLION)
TABLE 28. U.S. POULTRY VACCINE, BY DOSAGE FORM, 2022-2032 ($MILLION)
TABLE 29. U.S. POULTRY VACCINE, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 30. U.S. POULTRY VACCINE, BY END USER, 2022-2032 ($MILLION)
TABLE 31. CANADA POULTRY VACCINE, BY DISEASE TYPE, 2022-2032 ($MILLION)
TABLE 32. CANADA POULTRY VACCINE, BY PRODUCT TYPE, 2022-2032 ($MILLION)
TABLE 33. CANADA POULTRY VACCINE, BY DOSAGE FORM, 2022-2032 ($MILLION)
TABLE 34. CANADA POULTRY VACCINE, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 35. CANADA POULTRY VACCINE, BY END USER, 2022-2032 ($MILLION)
TABLE 36. MEXICO POULTRY VACCINE, BY DISEASE TYPE, 2022-2032 ($MILLION)
TABLE 37. MEXICO POULTRY VACCINE, BY PRODUCT TYPE, 2022-2032 ($MILLION)
TABLE 38. MEXICO POULTRY VACCINE, BY DOSAGE FORM, 2022-2032 ($MILLION)
TABLE 39. MEXICO POULTRY VACCINE, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 40. MEXICO POULTRY VACCINE, BY END USER, 2022-2032 ($MILLION)
TABLE 41. EUROPE POULTRY VACCINE, BY REGION, 2022-2032 ($MILLION)
TABLE 42. EUROPE POULTRY VACCINE, BY DISEASE TYPE, 2022-2032 ($MILLION)
TABLE 43. EUROPE POULTRY VACCINE, BY PRODUCT TYPE, 2022-2032 ($MILLION)
TABLE 44. EUROPE POULTRY VACCINE, BY DOSAGE FORM, 2022-2032 ($MILLION)
TABLE 45. EUROPE POULTRY VACCINE, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 46. EUROPE POULTRY VACCINE, BY END USER, 2022-2032 ($MILLION)
TABLE 47. FRANCE POULTRY VACCINE, BY DISEASE TYPE, 2022-2032 ($MILLION)
TABLE 48. FRANCE POULTRY VACCINE, BY PRODUCT TYPE, 2022-2032 ($MILLION)
TABLE 49. FRANCE POULTRY VACCINE, BY DOSAGE FORM, 2022-2032 ($MILLION)
TABLE 50. FRANCE POULTRY VACCINE, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 51. FRANCE POULTRY VACCINE, BY END USER, 2022-2032 ($MILLION)
TABLE 52. GERMANY POULTRY VACCINE, BY DISEASE TYPE, 2022-2032 ($MILLION)
TABLE 53. GERMANY POULTRY VACCINE, BY PRODUCT TYPE, 2022-2032 ($MILLION)
TABLE 54. GERMANY POULTRY VACCINE, BY DOSAGE FORM, 2022-2032 ($MILLION)
TABLE 55. GERMANY POULTRY VACCINE, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 56. GERMANY POULTRY VACCINE, BY END USER, 2022-2032 ($MILLION)
TABLE 57. ITALY POULTRY VACCINE, BY DISEASE TYPE, 2022-2032 ($MILLION)
TABLE 58. ITALY POULTRY VACCINE, BY PRODUCT TYPE, 2022-2032 ($MILLION)
TABLE 59. ITALY POULTRY VACCINE, BY DOSAGE FORM, 2022-2032 ($MILLION)
TABLE 60. ITALY POULTRY VACCINE, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 61. ITALY POULTRY VACCINE, BY END USER, 2022-2032 ($MILLION)
TABLE 62. SPAIN POULTRY VACCINE, BY DISEASE TYPE, 2022-2032 ($MILLION)
TABLE 63. SPAIN POULTRY VACCINE, BY PRODUCT TYPE, 2022-2032 ($MILLION)
TABLE 64. SPAIN POULTRY VACCINE, BY DOSAGE FORM, 2022-2032 ($MILLION)
TABLE 65. SPAIN POULTRY VACCINE, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 66. SPAIN POULTRY VACCINE, BY END USER, 2022-2032 ($MILLION)
TABLE 67. UK POULTRY VACCINE, BY DISEASE TYPE, 2022-2032 ($MILLION)
TABLE 68. UK POULTRY VACCINE, BY PRODUCT TYPE, 2022-2032 ($MILLION)
TABLE 69. UK POULTRY VACCINE, BY DOSAGE FORM, 2022-2032 ($MILLION)
TABLE 70. UK POULTRY VACCINE, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 71. UK POULTRY VACCINE, BY END USER, 2022-2032 ($MILLION)
TABLE 72. RUSSIA POULTRY VACCINE, BY DISEASE TYPE, 2022-2032 ($MILLION)
TABLE 73. RUSSIA POULTRY VACCINE, BY PRODUCT TYPE, 2022-2032 ($MILLION)
TABLE 74. RUSSIA POULTRY VACCINE, BY DOSAGE FORM, 2022-2032 ($MILLION)
TABLE 75. RUSSIA POULTRY VACCINE, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 76. RUSSIA POULTRY VACCINE, BY END USER, 2022-2032 ($MILLION)
TABLE 77. REST OF EUROPE POULTRY VACCINE, BY DISEASE TYPE, 2022-2032 ($MILLION)
TABLE 78. REST OF EUROPE POULTRY VACCINE, BY PRODUCT TYPE, 2022-2032 ($MILLION)
TABLE 79. REST OF EUROPE POULTRY VACCINE, BY DOSAGE FORM, 2022-2032 ($MILLION)
TABLE 80. REST OF EUROPE POULTRY VACCINE, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 81. REST OF EUROPE POULTRY VACCINE, BY END USER, 2022-2032 ($MILLION)
TABLE 82. ASIA-PACIFIC POULTRY VACCINE, BY REGION, 2022-2032 ($MILLION)
TABLE 83. ASIA-PACIFIC POULTRY VACCINE, BY DISEASE TYPE, 2022-2032 ($MILLION)
TABLE 84. ASIA-PACIFIC POULTRY VACCINE, BY PRODUCT TYPE, 2022-2032 ($MILLION)
TABLE 85. ASIA-PACIFIC POULTRY VACCINE, BY DOSAGE FORM, 2022-2032 ($MILLION)
TABLE 86. ASIA-PACIFIC POULTRY VACCINE, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 87. ASIA-PACIFIC POULTRY VACCINE, BY END USER, 2022-2032 ($MILLION)
TABLE 88. CHINA POULTRY VACCINE, BY DISEASE TYPE, 2022-2032 ($MILLION)
TABLE 89. CHINA POULTRY VACCINE, BY PRODUCT TYPE, 2022-2032 ($MILLION)
TABLE 90. CHINA POULTRY VACCINE, BY DOSAGE FORM, 2022-2032 ($MILLION)
TABLE 91. CHINA POULTRY VACCINE, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 92. CHINA POULTRY VACCINE, BY END USER, 2022-2032 ($MILLION)
TABLE 93. JAPAN POULTRY VACCINE, BY DISEASE TYPE, 2022-2032 ($MILLION)
TABLE 94. JAPAN POULTRY VACCINE, BY PRODUCT TYPE, 2022-2032 ($MILLION)
TABLE 95. JAPAN POULTRY VACCINE, BY DOSAGE FORM, 2022-2032 ($MILLION)
TABLE 96. JAPAN POULTRY VACCINE, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 97. JAPAN POULTRY VACCINE, BY END USER, 2022-2032 ($MILLION)
TABLE 98. INDIA POULTRY VACCINE, BY DISEASE TYPE, 2022-2032 ($MILLION)
TABLE 99. INDIA POULTRY VACCINE, BY PRODUCT TYPE, 2022-2032 ($MILLION)
TABLE 100. INDIA POULTRY VACCINE, BY DOSAGE FORM, 2022-2032 ($MILLION)
TABLE 101. INDIA POULTRY VACCINE, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 102. INDIA POULTRY VACCINE, BY END USER, 2022-2032 ($MILLION)
TABLE 103. SOUTH KOREA POULTRY VACCINE, BY DISEASE TYPE, 2022-2032 ($MILLION)
TABLE 104. SOUTH KOREA POULTRY VACCINE, BY PRODUCT TYPE, 2022-2032 ($MILLION)
TABLE 105. SOUTH KOREA POULTRY VACCINE, BY DOSAGE FORM, 2022-2032 ($MILLION)
TABLE 106. SOUTH KOREA POULTRY VACCINE, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 107. SOUTH KOREA POULTRY VACCINE, BY END USER, 2022-2032 ($MILLION)
TABLE 108. AUSTRALIA POULTRY VACCINE, BY DISEASE TYPE, 2022-2032 ($MILLION)
TABLE 109. AUSTRALIA POULTRY VACCINE, BY PRODUCT TYPE, 2022-2032 ($MILLION)
TABLE 110. AUSTRALIA POULTRY VACCINE, BY DOSAGE FORM, 2022-2032 ($MILLION)
TABLE 111. AUSTRALIA POULTRY VACCINE, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 112. AUSTRALIA POULTRY VACCINE, BY END USER, 2022-2032 ($MILLION)
TABLE 113. THAILAND POULTRY VACCINE, BY DISEASE TYPE, 2022-2032 ($MILLION)
TABLE 114. THAILAND POULTRY VACCINE, BY PRODUCT TYPE, 2022-2032 ($MILLION)
TABLE 115. THAILAND POULTRY VACCINE, BY DOSAGE FORM, 2022-2032 ($MILLION)
TABLE 116. THAILAND POULTRY VACCINE, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 117. THAILAND POULTRY VACCINE, BY END USER, 2022-2032 ($MILLION)
TABLE 118. MALAYSIA POULTRY VACCINE, BY DISEASE TYPE, 2022-2032 ($MILLION)
TABLE 119. MALAYSIA POULTRY VACCINE, BY PRODUCT TYPE, 2022-2032 ($MILLION)
TABLE 120. MALAYSIA POULTRY VACCINE, BY DOSAGE FORM, 2022-2032 ($MILLION)
TABLE 121. MALAYSIA POULTRY VACCINE, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 122. MALAYSIA POULTRY VACCINE, BY END USER, 2022-2032 ($MILLION)
TABLE 123. INDONESIA POULTRY VACCINE, BY DISEASE TYPE, 2022-2032 ($MILLION)
TABLE 124. INDONESIA POULTRY VACCINE, BY PRODUCT TYPE, 2022-2032 ($MILLION)
TABLE 125. INDONESIA POULTRY VACCINE, BY DOSAGE FORM, 2022-2032 ($MILLION)
TABLE 126. INDONESIA POULTRY VACCINE, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 127. INDONESIA POULTRY VACCINE, BY END USER, 2022-2032 ($MILLION)
TABLE 128. REST OF ASIA PACIFIC POULTRY VACCINE, BY DISEASE TYPE, 2022-2032 ($MILLION)
TABLE 129. REST OF ASIA PACIFIC POULTRY VACCINE, BY PRODUCT TYPE, 2022-2032 ($MILLION)
TABLE 130. REST OF ASIA PACIFIC POULTRY VACCINE, BY DOSAGE FORM, 2022-2032 ($MILLION)
TABLE 131. REST OF ASIA PACIFIC POULTRY VACCINE, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 132. REST OF ASIA PACIFIC POULTRY VACCINE, BY END USER, 2022-2032 ($MILLION)
TABLE 133. LAMEA POULTRY VACCINE, BY REGION, 2022-2032 ($MILLION)
TABLE 134. LAMEA POULTRY VACCINE, BY DISEASE TYPE, 2022-2032 ($MILLION)
TABLE 135. LAMEA POULTRY VACCINE, BY PRODUCT TYPE, 2022-2032 ($MILLION)
TABLE 136. LAMEA POULTRY VACCINE, BY DOSAGE FORM, 2022-2032 ($MILLION)
TABLE 137. LAMEA POULTRY VACCINE, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 138. LAMEA POULTRY VACCINE, BY END USER, 2022-2032 ($MILLION)
TABLE 139. BRAZIL POULTRY VACCINE, BY DISEASE TYPE, 2022-2032 ($MILLION)
TABLE 140. BRAZIL POULTRY VACCINE, BY PRODUCT TYPE, 2022-2032 ($MILLION)
TABLE 141. BRAZIL POULTRY VACCINE, BY DOSAGE FORM, 2022-2032 ($MILLION)
TABLE 142. BRAZIL POULTRY VACCINE, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 143. BRAZIL POULTRY VACCINE, BY END USER, 2022-2032 ($MILLION)
TABLE 144. SOUTH AFRICA POULTRY VACCINE, BY DISEASE TYPE, 2022-2032 ($MILLION)
TABLE 145. SOUTH AFRICA POULTRY VACCINE, BY PRODUCT TYPE, 2022-2032 ($MILLION)
TABLE 146. SOUTH AFRICA POULTRY VACCINE, BY DOSAGE FORM, 2022-2032 ($MILLION)
TABLE 147. SOUTH AFRICA POULTRY VACCINE, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 148. SOUTH AFRICA POULTRY VACCINE, BY END USER, 2022-2032 ($MILLION)
TABLE 149. SAUDI ARABIA POULTRY VACCINE, BY DISEASE TYPE, 2022-2032 ($MILLION)
TABLE 150. SAUDI ARABIA POULTRY VACCINE, BY PRODUCT TYPE, 2022-2032 ($MILLION)
TABLE 151. SAUDI ARABIA POULTRY VACCINE, BY DOSAGE FORM, 2022-2032 ($MILLION)
TABLE 152. SAUDI ARABIA POULTRY VACCINE, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 153. SAUDI ARABIA POULTRY VACCINE, BY END USER, 2022-2032 ($MILLION)
TABLE 154. UAE POULTRY VACCINE, BY DISEASE TYPE, 2022-2032 ($MILLION)
TABLE 155. UAE POULTRY VACCINE, BY PRODUCT TYPE, 2022-2032 ($MILLION)
TABLE 156. UAE POULTRY VACCINE, BY DOSAGE FORM, 2022-2032 ($MILLION)
TABLE 157. UAE POULTRY VACCINE, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 158. UAE POULTRY VACCINE, BY END USER, 2022-2032 ($MILLION)
TABLE 159. ARGENTINA POULTRY VACCINE, BY DISEASE TYPE, 2022-2032 ($MILLION)
TABLE 160. ARGENTINA POULTRY VACCINE, BY PRODUCT TYPE, 2022-2032 ($MILLION)
TABLE 161. ARGENTINA POULTRY VACCINE, BY DOSAGE FORM, 2022-2032 ($MILLION)
TABLE 162. ARGENTINA POULTRY VACCINE, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 163. ARGENTINA POULTRY VACCINE, BY END USER, 2022-2032 ($MILLION)
TABLE 164. REST OF LAMEA POULTRY VACCINE, BY DISEASE TYPE, 2022-2032 ($MILLION)
TABLE 165. REST OF LAMEA POULTRY VACCINE, BY PRODUCT TYPE, 2022-2032 ($MILLION)
TABLE 166. REST OF LAMEA POULTRY VACCINE, BY DOSAGE FORM, 2022-2032 ($MILLION)
TABLE 167. REST OF LAMEA POULTRY VACCINE, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 168. REST OF LAMEA POULTRY VACCINE, BY END USER, 2022-2032 ($MILLION)
TABLE 169. HESTER BIOSCIENCES LIMITED,: KEY EXECUTIVES
TABLE 170. HESTER BIOSCIENCES LIMITED,: COMPANY SNAPSHOT
TABLE 171. HESTER BIOSCIENCES LIMITED,: OPERATING SEGMENTS
TABLE 172. HESTER BIOSCIENCES LIMITED,: PRODUCT PORTFOLIO
TABLE 173. HESTER BIOSCIENCES LIMITED,: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 174. BIOVAC, ZOETIS INC.,: KEY EXECUTIVES
TABLE 175. BIOVAC, ZOETIS INC.,: COMPANY SNAPSHOT
TABLE 176. BIOVAC, ZOETIS INC.,: OPERATING SEGMENTS
TABLE 177. BIOVAC, ZOETIS INC.,: PRODUCT PORTFOLIO
TABLE 178. BIOVAC, ZOETIS INC.,: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 179. MERCK AND CO.,: KEY EXECUTIVES
TABLE 180. MERCK AND CO.,: COMPANY SNAPSHOT
TABLE 181. MERCK AND CO.,: OPERATING SEGMENTS
TABLE 182. MERCK AND CO.,: PRODUCT PORTFOLIO
TABLE 183. MERCK AND CO.,: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 184. BORHRINGER INGELHEIM,: KEY EXECUTIVES
TABLE 185. BORHRINGER INGELHEIM,: COMPANY SNAPSHOT
TABLE 186. BORHRINGER INGELHEIM,: OPERATING SEGMENTS
TABLE 187. BORHRINGER INGELHEIM,: PRODUCT PORTFOLIO
TABLE 188. BORHRINGER INGELHEIM,: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 189. BIO-VET,: KEY EXECUTIVES
TABLE 190. BIO-VET,: COMPANY SNAPSHOT
TABLE 191. BIO-VET,: OPERATING SEGMENTS
TABLE 192. BIO-VET,: PRODUCT PORTFOLIO
TABLE 193. BIO-VET,: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 194. CEVA ANIMAL HEALTH,: KEY EXECUTIVES
TABLE 195. CEVA ANIMAL HEALTH,: COMPANY SNAPSHOT
TABLE 196. CEVA ANIMAL HEALTH,: OPERATING SEGMENTS
TABLE 197. CEVA ANIMAL HEALTH,: PRODUCT PORTFOLIO
TABLE 198. CEVA ANIMAL HEALTH,: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 199. PHIBRO ANIMAL HEALTH CORPORATION: KEY EXECUTIVES
TABLE 200. PHIBRO ANIMAL HEALTH CORPORATION: COMPANY SNAPSHOT
TABLE 201. PHIBRO ANIMAL HEALTH CORPORATION: OPERATING SEGMENTS
TABLE 202. PHIBRO ANIMAL HEALTH CORPORATION: PRODUCT PORTFOLIO
TABLE 203. PHIBRO ANIMAL HEALTH CORPORATION: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 204. VENKYS,: KEY EXECUTIVES
TABLE 205. VENKYS,: COMPANY SNAPSHOT
TABLE 206. VENKYS,: OPERATING SEGMENTS
TABLE 207. VENKYS,: PRODUCT PORTFOLIO
TABLE 208. VENKYS,: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 209. RINGPU BIOLOGY,: KEY EXECUTIVES
TABLE 210. RINGPU BIOLOGY,: COMPANY SNAPSHOT
TABLE 211. RINGPU BIOLOGY,: OPERATING SEGMENTS
TABLE 212. RINGPU BIOLOGY,: PRODUCT PORTFOLIO
TABLE 213. RINGPU BIOLOGY,: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 214. ANICON GMBH: KEY EXECUTIVES
TABLE 215. ANICON GMBH: COMPANY SNAPSHOT
TABLE 216. ANICON GMBH: OPERATING SEGMENTS
TABLE 217. ANICON GMBH: PRODUCT PORTFOLIO
TABLE 218. ANICON GMBH: KEY STRATEGIC MOVES AND DEVELOPMENTS

LIST OF FIGURES
FIGURE 1. GLOBAL POULTRY VACCINE MARKET SEGMENTATION
FIGURE 2. GLOBAL POULTRY VACCINE MARKET
FIGURE 3. SEGMENTATION POULTRY VACCINE MARKET
FIGURE 4. TOP INVESTMENT POCKET IN POULTRY VACCINE MARKET
FIGURE 5. MODERATE BARGAINING POWER OF BUYERS
FIGURE 6. MODERATE BARGAINING POWER OF SUPPLIERS
FIGURE 7. MODERATE THREAT OF NEW ENTRANTS
FIGURE 8. LOW THREAT OF SUBSTITUTION
FIGURE 9. HIGH COMPETITIVE RIVALRY
FIGURE 10. OPPORTUNITIES, RESTRAINTS AND DRIVERS: GLOBALPOULTRY VACCINE MARKET
FIGURE 11. POULTRY VACCINE MARKET SEGMENTATION, BY BY DISEASE TYPE
FIGURE 12. POULTRY VACCINE MARKET FOR AVIAN INFLUENZA, BY COUNTRY, 2022-2032 ($MILLION)
FIGURE 13. POULTRY VACCINE MARKET FOR INFECTIOUS BRONCHITIS, BY COUNTRY, 2022-2032 ($MILLION)
FIGURE 14. POULTRY VACCINE MARKET SEGMENTATION, BY BY PRODUCT TYPE
FIGURE 15. POULTRY VACCINE MARKET FOR RECOMBINANT VACCINE, BY COUNTRY, 2022-2032 ($MILLION)
FIGURE 16. POULTRY VACCINE MARKET FOR LIVE ATTENUATED VACCINE, BY COUNTRY, 2022-2032 ($MILLION)
FIGURE 17. POULTRY VACCINE MARKET FOR INACTIVATED VACCINE, BY COUNTRY, 2022-2032 ($MILLION)
FIGURE 18. POULTRY VACCINE MARKET FOR OTHERS, BY COUNTRY, 2022-2032 ($MILLION)
FIGURE 19. POULTRY VACCINE MARKET SEGMENTATION, BY BY DOSAGE FORM
FIGURE 20. POULTRY VACCINE MARKET FOR LIQUID VACCINE, BY COUNTRY, 2022-2032 ($MILLION)
FIGURE 21. POULTRY VACCINE MARKET FOR FREEZE DRIED VACCINE, BY COUNTRY, 2022-2032 ($MILLION)
FIGURE 22. POULTRY VACCINE MARKET SEGMENTATION, BY BY APPLICATION
FIGURE 23. POULTRY VACCINE MARKET FOR BREEDER, BY COUNTRY, 2022-2032 ($MILLION)
FIGURE 24. POULTRY VACCINE MARKET FOR BROILER, BY COUNTRY, 2022-2032 ($MILLION)
FIGURE 25. POULTRY VACCINE MARKET SEGMENTATION, BY BY END USER
FIGURE 26. POULTRY VACCINE MARKET FOR VETERINARY HOSPITALS, BY COUNTRY, 2022-2032 ($MILLION)
FIGURE 27. POULTRY VACCINE MARKET FOR POULTRY FIRM, BY COUNTRY, 2022-2032 ($MILLION)
FIGURE 28. POULTRY VACCINE MARKET FOR POULTRY VACCINATION CENTER, BY COUNTRY, 2022-2032 ($MILLION)
FIGURE 29. TOP WINNING STRATEGIES, BY YEAR, 2020-2022*
FIGURE 30. TOP WINNING STRATEGIES, BY DEVELOPMENT, 2020-2022*
FIGURE 31. TOP WINNING STRATEGIES, BY COMPANY, 2020-2022*
FIGURE 32. PRODUCT MAPPING OF TOP 10 PLAYERS
FIGURE 33. COMPETITIVE DASHBOARD
FIGURE 34. COMPETITIVE HEATMAP: POULTRY VACCINE MARKET
FIGURE 35. Top player positioning, 2022
FIGURE 36. HESTER BIOSCIENCES LIMITED,: NET SALES, 2020-2022 ($MILLION)
FIGURE 37. HESTER BIOSCIENCES LIMITED,: REVENUE SHARE, BY SEGMENT, 2032 (%)
FIGURE 38. HESTER BIOSCIENCES LIMITED,: REVENUE SHARE, BY REGION, 2032 (%)
FIGURE 39. BIOVAC, ZOETIS INC.,: NET SALES, 2020-2022 ($MILLION)
FIGURE 40. BIOVAC, ZOETIS INC.,: REVENUE SHARE, BY SEGMENT, 2032 (%)
FIGURE 41. BIOVAC, ZOETIS INC.,: REVENUE SHARE, BY REGION, 2032 (%)
FIGURE 42. MERCK AND CO.,: NET SALES, 2020-2022 ($MILLION)
FIGURE 43. MERCK AND CO.,: REVENUE SHARE, BY SEGMENT, 2032 (%)
FIGURE 44. MERCK AND CO.,: REVENUE SHARE, BY REGION, 2032 (%)
FIGURE 45. BORHRINGER INGELHEIM,: NET SALES, 2020-2022 ($MILLION)
FIGURE 46. BORHRINGER INGELHEIM,: REVENUE SHARE, BY SEGMENT, 2032 (%)
FIGURE 47. BORHRINGER INGELHEIM,: REVENUE SHARE, BY REGION, 2032 (%)
FIGURE 48. BIO-VET,: NET SALES, 2020-2022 ($MILLION)
FIGURE 49. BIO-VET,: REVENUE SHARE, BY SEGMENT, 2032 (%)
FIGURE 50. BIO-VET,: REVENUE SHARE, BY REGION, 2032 (%)
FIGURE 51. CEVA ANIMAL HEALTH,: NET SALES, 2020-2022 ($MILLION)
FIGURE 52. CEVA ANIMAL HEALTH,: REVENUE SHARE, BY SEGMENT, 2032 (%)
FIGURE 53. CEVA ANIMAL HEALTH,: REVENUE SHARE, BY REGION, 2032 (%)
FIGURE 54. PHIBRO ANIMAL HEALTH CORPORATION: NET SALES, 2020-2022 ($MILLION)
FIGURE 55. PHIBRO ANIMAL HEALTH CORPORATION: REVENUE SHARE, BY SEGMENT, 2032 (%)
FIGURE 56. PHIBRO ANIMAL HEALTH CORPORATION: REVENUE SHARE, BY REGION, 2032 (%)
FIGURE 57. VENKYS,: NET SALES, 2020-2022 ($MILLION)
FIGURE 58. VENKYS,: REVENUE SHARE, BY SEGMENT, 2032 (%)
FIGURE 59. VENKYS,: REVENUE SHARE, BY REGION, 2032 (%)
FIGURE 60. RINGPU BIOLOGY,: NET SALES, 2020-2022 ($MILLION)
FIGURE 61. RINGPU BIOLOGY,: REVENUE SHARE, BY SEGMENT, 2032 (%)
FIGURE 62. RINGPU BIOLOGY,: REVENUE SHARE, BY REGION, 2032 (%)
FIGURE 63. ANICON GMBH: NET SALES, 2020-2022 ($MILLION)
FIGURE 64. ANICON GMBH: REVENUE SHARE, BY SEGMENT, 2032 (%)
FIGURE 65. ANICON GMBH: REVENUE SHARE, BY REGION, 2032 (%)

With collective industry experience of about 200 years of its analysts and experts, Allied Market Research (AMR) encompasses most infallible research methodology for its market intelligence and industry analysis. We do not only engrave the deepest levels of markets but also sneak through its slimmest details for the purpose of our market estimates and forecasts. Our approach helps in building greater market consensus view for size, shape and industry trends within each industry segment. We carefully factor in industry trends and real developments for identifying key growth factors and future course of the market. Our research proceeds are the resultant of high quality data, expert views and analysis and high value independent opinions. Our research process is designed to deliver balanced view of the global markets and allow stakeholders to make informed decisions.

We offer our clients exhaustive research and analysis based on wide variety of factual inputs, which largely include interviews with industry participants, reliable statistics and regional intelligence. Our in-house industry experts play instrumental role in designing analytic tools and models, tailored to the requirements of particular industry segment. These analytical tools and models sanitize the data & statistics and enhance the accuracy of our recommendations and advice. With AMR’s calibrated research process and 360` degree data-evaluation methodology, our clients are assured of receiving:

Consistent, valuable, robust and actionable data & analysis that can easily be referenced for strategic business planning
Technologically sophisticated and reliable insights through well audited and veracious research methodology
Sovereign research proceeds that present a tangible depiction of marketplace

With a strong methodology we are, therefore, confident that our research and analysis are most reliable and guarantees sound business planning.

Secondary research
We refer a broad array of industry sources for our secondary, which typically include; however, not limited to: Company SEC filings, annual reports, company websites, broker & financial reports and investor presentations for competitive scenario and shape of the industry

Patent and regulatory databases for understanding of technical & legal developments
Scientific and technical writings for product information and related preemptions
Regional government and statistical databases for macro analysis
Authentic new articles, web-casts and other related releases for market evaluation
Internal and external proprietary databases, key market indicators and relevant press releases for market estimates and forecast

Primary research
Our primary research efforts include reaching out participants through mail, tele-conversations, referrals, professional networks and face-to-face interactions. We are also in professional corporate relations with various companies that allow us greater flexibility for reaching out industry participants and commentators for interviews and discussions, fulfilling following functions:

Validates and improves the data quality and strengthens research proceeds
Further develops analyst team’s market understanding and expertise
Supplies authentic information about market size, share, growth and forecasts

Our primary research interview and discussion panels are typically composed of most experienced industry members. These participants include; however, not limited to:

Chief executives and VPs of leading corporations specific to industry
Product and sales managers or country heads; channel partners and top level distributors; banking, investments and valuation experts Key opinion leaders (KOLs)

Analyst tools and models
AMR has developed set of analyst tools and data models to supplement and expedite the analysis process. Corresponding to markets, where there is significant lack of information and estimates, AMR’s team of experts and analyst develop specific analyst tools and industry models to translate qualitative and quantitative industry indicators into exact industry estimates. These models also allow analysts to examine the prospects and opportunities prevailing in the market to accurately forecast the course of the market.

U.S.-Canada Toll-free: +1-800-792-5285
Int'l :	+1-503-894-6022
Europe :	+44-845-528-1300
Email :	help@alliedmarketresearch.com

Life Sciences	Construction & Manufacturing	Semiconductor & Electronics
Consumer Goods	Food & Beverages	Automotive & Tarnsportation
Materials & Chemicals	Energy & Power	ICT & Media
Aerospace & Defense	BFSI
You must check at least one industry.

Your Shopping Cart Is Empty

Continue Shopping

Poultry Vaccine Market: Global Opportunity Analysis and Industry Forecast, 2019–2027 Global Opportunity Analysis and Industry Forecast, 2019–2027

2023

Poultry Vaccine Market

Poultry Vaccine Market: Global Opportunity Analysis and Industry Forecast, 2019-2027 Market

COVID-19

Top impacting factors: Market Scenario Analysis, Trends, Drivers and Impact Analysis:

New product launches to flourish the market

CHAPTER 1: INTRODUCTION

1.1. Report Description

1.2. Key Market Segments

1.3. Key Benefits

1.4. Research Methodology

1.4.1. Primary Research

1.4.2. Secondary Research

1.4.3. Analyst Tools and Models

CHAPTER 2: EXECUTIVE SUMMARY

2.1. CXO Perspective

CHAPTER 3: MARKET LANDSCAPE

3.1. Market Definition and Scope

3.2. Key Findings

3.2.1. Top Investment Pockets

3.2.2. Top Winning Strategies

3.3. Porter's Five Forces Analysis

3.3.1. Bargaining Power of Suppliers

3.3.2. Threat of New Entrants

3.3.3. Threat of Substitutes

3.3.4. Competitive Rivalry

3.3.5. Bargaining Power among Buyers

3.5. Market Dynamics

3.5.1. Drivers

3.5.2. Restraints

3.5.3. Opportunities

3.6. COVID-19 Impact Analysis

CHAPTER 4: POULTRY VACCINE MARKET, BY DISEASE TYPE

4.1. Market Overview

4.1.1 Market Size and Forecast, By Disease Type

4.2. Avian Influenza

4.2.1. Key Market Trends, Growth Factors and Opportunities

4.2.2. Market Size and Forecast, By Region

4.2.3. Market Share Analysis, By Country

4.3. Infectious Bronchitis

4.3.1. Key Market Trends, Growth Factors and Opportunities

4.3.2. Market Size and Forecast, By Region

4.3.3. Market Share Analysis, By Country

CHAPTER 5: POULTRY VACCINE MARKET, BY PRODUCT TYPE

5.1. Market Overview

5.1.1 Market Size and Forecast, By Product Type

5.2. Recombinant Vaccine

5.2.1. Key Market Trends, Growth Factors and Opportunities

5.2.2. Market Size and Forecast, By Region

5.2.3. Market Share Analysis, By Country

5.3. Live Attenuated Vaccine

5.3.1. Key Market Trends, Growth Factors and Opportunities

5.3.2. Market Size and Forecast, By Region

5.3.3. Market Share Analysis, By Country

5.4. Inactivated Vaccine

5.4.1. Key Market Trends, Growth Factors and Opportunities

5.4.2. Market Size and Forecast, By Region

5.4.3. Market Share Analysis, By Country

5.5. Others

5.5.1. Key Market Trends, Growth Factors and Opportunities

5.5.2. Market Size and Forecast, By Region

5.5.3. Market Share Analysis, By Country

CHAPTER 6: POULTRY VACCINE MARKET, BY DOSAGE FORM

6.1. Market Overview

6.1.1 Market Size and Forecast, By Dosage Form

6.2. Liquid Vaccine

6.2.1. Key Market Trends, Growth Factors and Opportunities

6.2.2. Market Size and Forecast, By Region

6.2.3. Market Share Analysis, By Country

6.3. Freeze Dried Vaccine

6.3.1. Key Market Trends, Growth Factors and Opportunities

6.3.2. Market Size and Forecast, By Region

6.3.3. Market Share Analysis, By Country

CHAPTER 7: POULTRY VACCINE MARKET, BY APPLICATION

7.1. Market Overview

7.1.1 Market Size and Forecast, By Application

7.2. Breeder

Poultry Vaccine Market: Global Opportunity Analysis and Industry Forecast, 2019–2027
Global Opportunity Analysis and Industry Forecast, 2019–2027